NOBILIS ND C2
NOBILIS ND C2
Authorised
- Newcastle disease virus, Live
Product identification
Medicine name:
Nobilis ND C2 liofilizado para suspensão oculonasal para galinhas
NOBILIS ND C2
Active substance:
- Newcastle disease virus, Live
Target species:
-
Chicken
Route of administration:
-
Oculonasal use
-
Nebulisation use
Product details
Active substance and strength:
-
Newcastle disease virus, Live5.70unit(s)1.00Dose
Pharmaceutical form:
-
Lyophilisate for suspension
Withdrawal period by route of administration:
-
Oculonasal use
- Chicken
-
All relevant tissues0day
-
-
Nebulisation use
- Chicken
-
All relevant tissues0day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD06
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Portugal
Package description:
- Cardboard box with 1 vial of 500 doses.
- Cardboard box with 1 vial of 5000 doses.
- PET plastic boxes with 12 cups of 5000 doses
- PET plastic boxes with 12 cups of 2500 doses
- PET plastic boxes with 12 cups of 10000 doses
- PET plastic boxes with 12 cups of 1000 doses
- Cardboard box with 1 vial of 25000 doses.
- Cardboard box with 1 vial of 2500 doses.
- Cardboard box with 1 vial of 10000 doses.
- Cardboard box with 1 vial of 1000 doses.
- Cardboard box with 10 vials of 1000 doses.
- Cardboard box with 10 vials of 10000 doses.
- Cardboard box with vials of 2500 doses.
- Cardboard box with 10 vials of 25000 doses.
- Cardboard box with 10 vials of 5000 doses.
- Cardboard box with 10 vials of 500 doses.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- MSD Animal Health Lda.
Marketing authorisation date:
Manufacturing sites for batch release:
- INTERVET INTERNATIONAL B.V.
Responsible authority:
- DGAV
Authorisation number:
- R746/05 DGV
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0113/001
Concerned member states:
-
Belgium
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Germany
-
Greece
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Poland
-
Portugal
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?: